Gastrointestinal bleeding (GIB) presents a diagnostic and therapeutic challenge to healthcare professionals. As an acute medical emergency, it requires a systematic approach for accurate diagnosis and effective management.
The first step in the clinical approach to GIB is identifying the source of the bleed, which can be broadly categorized into upper and lower GIB. Upper GIB, originating proximal to the ligament of Treitz, often presents with hematemesis or melena. Lower GIB, distal to the ligament, frequently results in hematochezia. However, these presentations can overlap, adding to the complexity of diagnosis.
Initial evaluation should include a thorough history, physical examination, and laboratory testing. Hemodynamic stability should be assessed and resuscitation initiated if necessary. Early risk stratification, using tools such as the Glasgow-Blatchford score, can guide management decisions and triage patients appropriately.
Endoscopic evaluation remains the cornerstone of diagnosis. Upper endoscopy and colonoscopy can identify the source of the bleed in most cases. If these are non-diagnostic, capsule endoscopy or angiography may be employed. In cases of obscure GIB, enteroscopy or radionuclide scanning may be considered.
Treatment of GIB depends on the source and severity of the bleed. Endoscopic therapy, including injection, coagulation, and mechanical therapies, is effective for most causes of GIB. In refractory cases, angiographic embolization or surgery may be necessary.
Managing GIB requires a comprehensive, systematic approach. Early identification, appropriate risk stratification, and timely intervention are key to improving patient outcomes. As our understanding of GIB continues to evolve, so too will our clinical approach, promising improved diagnostic and therapeutic strategies in the future.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation